You are here

Article info

Article menu

This article has a correction. Please see:

XML
Immunotherapy biomarkers
Original research
Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer

Authors

  • Peixin Chen Department of Medical Oncology, Shanghai Pulmonary Hospital,Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, ChinaTongji University, No 1239 Siping Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Liping Zhang Department of Pathology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Wei Zhang Department of Pathology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Chenglong Sun Department of Medical Oncology, Shanghai Pulmonary Hospital,Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, ChinaTongji University, No 1239 Siping Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Chunyan Wu Department of Pathology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Yayi He Department of Medical Oncology, Shanghai Pulmonary Hospital,Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Caicun Zhou Department of Medical Oncology, Shanghai Pulmonary Hospital,Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, China PubMed articlesGoogle scholar articles

Citation

Chen P, Zhang L, Zhang W, et al
Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer
Journal for ImmunoTherapy of Cancer 2020;8:e001391. doi: 10.1136/jitc-2020-001391
Online issue publication 
October 20, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.